CHEK2 and breast carcinoma: These studies definitively established that pathogenic variants in eight canonical genes, including BRCA1, BRCA2, PALB2, BARD1, RAD51C, RAD51D, ATM, and CHEK2, demonstrate significant association with increased breast cancer susceptibility.